• Ownership

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - Insider Trading & Ownership

Entity
Company
Location
280 Congress Street, Boston, MA
Summary
The estimated value of insider holdings of Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is at least $58.2M dollars as of February 3, 2025. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is the 10%+ Owner of RayzeBio, Inc. and owns shares of RayzeBio, Inc. stock worth about $28M. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $19.1M. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is the 10%+ Owner of CARGO Therapeutics, Inc. and owns shares of CARGO Therapeutics, Inc. (CRGX) stock worth about $11.1M.
All Insider Reports
All Insider Reports

Ownership of Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RYZB RayzeBio, Inc. 10%+ Owner $28M Sep 19, 2023
MBX MBX Biosciences, Inc. 10%+ Owner $19.1M Sep 16, 2024
CRGX CARGO Therapeutics, Inc. 10%+ Owner $11.1M Nov 14, 2023
MTSR Metsera, Inc. 10%+ Owner Jan 30, 2025
UPB Upstream Bio, Inc. 10%+ Owner Oct 15, 2024

Insider Transactions Reported by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.